Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie (Q47685389)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie |
scientific article |
Statements
1 reference
Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie (English)
1 reference
A Ravaud
1 reference
B Audhuy
1 reference
F Gomez
1 reference
B Escudier
1 reference
T Lesimple
1 reference
C Chevreau
1 reference
J Y Douillard
1 reference
A Caty
1 reference
L Geoffrois
1 reference
J M Ferrero
1 reference
C Linassier
1 reference
M Drevon
1 reference
S Négrier
1 reference
1 August 1998
1 reference
16
1 reference
8
1 reference
2728-2732
1 reference